Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Insider Monkey Presents a Bull Case Theory for Bristol-Myers Squibb Company

January 26, 2025
According to a recent report by Insider Monkey, Bristol-Myers Squibb Company (NYSE: BMY) is attracting a lot of attention from institutional investors who currently own 77% of the company. The pharmaceutical giant has been making waves in the industry with its latest product, which has everyone buzzing. However, professional stock analysts at Stocks Prognosis recommend cautious optimism when it comes to investing in BMY. They suggest seeking expert advice to make an informed decision on the future movement of the company's stocks.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

I'm curious to know more about Bristol-Myers Squibb's latest product and how it compares to others in the market
— from MoneyMandy at 01-29-2025 18:30
I have faith in Bristol-Myers Squibb's ability to innovate and deliver groundbreaking products. I'm confident that their latest offering will be a game-changer
— from LucasPrice at 01-28-2025 20:46
I'm not sure if Bristol-Myers Squibb's latest product will live up to the hype. I'll wait for more information before making a decision
— from FinanceLisa at 01-27-2025 23:42
I'm skeptical about Bristol-Myers Squibb's latest product and its potential impact. I'll need more evidence before considering an investment
— from JustinMitchell at 01-27-2025 15:07
I'm optimistic about Bristol-Myers Squibb's future and their latest product. I believe it will contribute to their continued success in the industry
— from WealthyWes at 01-27-2025 07:04
Bristol-Myers Squibb is a well-known pharmaceutical giant with a strong track record. I trust that their latest product will be successful
— from MeganMason at 01-27-2025 06:18
I can't wait to hear more about Bristol-Myers Squibb's latest product. I think it has great potential
— from AdamWells at 01-27-2025 02:51
I'm excited to see what Bristol-Myers Squibb's latest product is and how it will impact the industry
— from CharlotteCampbell at 01-27-2025 00:09
I'm not convinced that Bristol-Myers Squibb's latest product will be a game-changer. I'll wait and see how it performs before making any decisions
— from MeganThompson at 01-26-2025 21:41
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....



Related news

VRTXJanuary 2, 2025Vertex Pharmaceuticals Incorporated: Promising Future Ahead  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is gaining attention in the options market, with predictions of a potential spike in its stock. Brokerages have set a price target of $494....

VRTXJanuary 29, 2025Brighton Jones LLC Increases Stake in Vertex Pharmaceuticals VRTX  ~1 min.

Brighton Jones LLC, a prominent investment firm, has recently revealed that it has increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)....

VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....

VRTXFebruary 10, 2025Vertex Pharmaceuticals Announces Breakthrough FDA Approval  ~1 min.

Vertex Pharmaceuticals has recently received a major FDA approval for its groundbreaking drug. This approval is expected to have a significant impact on the company's future and its stock value....

VRTXJanuary 1, 2025Vertex Pharmaceuticals Inc. (VRTX) Sees Options Market Predicting a Spike  ~1 min.

Shares of Vertex Pharmaceuticals Inc. (VRTX) are expected to experience a significant increase, according to the options market....